Caw-it, Mark Anthony C.

HRN: 21-88-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/10/2022
09/15/2022
IV
500mg
TID
AGE
Waiting Final Action 
09/10/2022
CEFTRIAXONE 1G (VIAL)
09/10/2022
09/16/2022
IV
2gm
OD
UTI
Waiting Final Action 
09/13/2022
CEFIXIME 200MG (CAP)
09/13/2022
09/19/2022
PO
200mg
BID
Uti, Infecrtious Diarrhea
Waiting Final Action 
09/13/2022
METRONIDAZOLE 500MG (TAB)
09/13/2022
09/19/2022
PO
500 Mg
Tid
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: